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BACKGROUND: Spontaneous dizygotic (DZ) twinning in humans is under genetic control. In sheep, heterozygous
loss of function mutations in bone morphogenetic protein 15 (BMP15) increase ovulation and hence twinning rates.
METHODS: To investigate the role of BMP15 in human twinning, we typed 14 common variants, 4 rare novel variants
initially detected by sequencing 279 mothers of DZ twins (MODZT) and 17 variants previously associated with pre-
mature ovarian failure (POF) in 933 DZ twinning families. We also typed five additional POF associated GDF9 var-
iants. RESULTS: There was some evidence for association between DZ twinning and a common intronic BMP15
variant (rs3897937), but this was not significant after correction for multiple testing. Three of the four novel variants
(p.Pro174Ser, p.Ala311Thr and p.Arg392Thr) occurred in 1–5 MODZT but were not detected in 1512 controls. We
also detected three POF associated mutations in both BMP15 and GDF9 at low frequencies in MODZT and controls.
CONCLUSIONS: We conclude that neither rare nor common BMP15 variants play a significant role in the variation
in human DZ twinning.
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Introduction
The transforming growth factor signalling pathway within the
ovary is critical for the regulation of ovarian function, ovu-
lation rate and fertility (Moore et al., 2004; Shimasaki et al.,
2004). Two genes in this pathway are growth differentiation
factor 9 (GDF9) on chromosome 5 and bone morphogenetic
protein 15 (BMP15) on the X chromosome. Loss of function
of Gdf9 in female mice blocks folliculogenesis during early
follicle development and leads to infertility (McGrath et al.,
1995). In sheep, the effects of mutations in both GDF9 and
BMP15 are sensitive to copy number. Heterozygous mutations
in both genes increase the frequency of twins and higher order
multiples, whereas homozygous loss of function mutations
results in ovarian dysgenesis and infertility (Galloway et al.,
2000; Hanrahan et al., 2004).
This pathway is also essential for human fertility (Di Pasquale
et al., 2004). Two sisters with hypergonadotrophic ovarian
failure due to ovarian dysgenesis were found to carry a non-
conservative amino acid substitution in the pro region of
BMP15 (p.Tyr235Cys) which acts in a dominant negative
fashion by altering BMP15 processing (Di Pasquale et al.,
2004). Rare variants in both BMP15 and GDF9 contribute to
premature ovarian failure (POF) (Di Pasquale et al., 2004,
2006; Dixit et al., 2005, 2006; Laissue et al., 2006). Addition-
ally, we found that some mothers of spontaneous dizygotic
(DZ) twins (MODZT) carry rare deletions and missense
mutations in the coding region of GDF9 that are significantly
associated with twinning (Montgomery et al., 2004; Palmer
et al., 2006).
BMP15 is expressed in oocytes in several mammalian
species (Laitinen et al., 1998; Galloway et al., 2000; Otsuka
et al., 2000). The protein has six conserved cysteine residues
characteristic of the TGFb superfamily, but lacks the additional
cysteine residue that strengthens dimerization in other
members of the bone morphogenetic protein family (Vitt
et al., 2001). BMP15 stimulates granulosa cell proliferation
(Otsuka et al., 2000), inhibits follicle-stimulating hormone
receptor (FSHR) expression (Otsuka et al., 2001) and stimu-
lates KIT ligand expression (Otsuka and Shimasaki, 2002).
Five different heterozygous mutations in the coding region
of BMP15 in different lines of sheep increase ovulation rate
and litter size (McNatty et al., 2004). It is unknown if variants
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in BMP15 contribute to variation in human twinning. The
human BMP15 sequence has a number of variants that alter
the predicted protein sequence, including rs41308602
(c.308A.G) located in the second position of codon 103 of
the preproprotein that changes the amino acid from an aspara-
gine to a serine. We hypothesized that variation in BMP15may
contribute to the variation in human twinning and genotyped
common variants identified from the literature and public data-
bases in families of MODZT and controls. We also searched
for rare variants by conducting a mutation screen of the
coding region of the BMP15 gene in a subset of MODZT and
typed these novel variants in additional families to determine
whether these are associated with DZ twinning. Further, we
typed rare BMP15 and GDF9 variants previously reported in
patients with POF to determine whether these POF associated
variants might contribute to the risk for DZ twinning.
Materials and Methods
Experimental subjects
Study subjects were Caucasians recruited from 933 families with a
history of DZ twinning (770 families from Australia and New
Zealand and 163 families from the Netherlands) with 3450 individuals
available for genotyping, including 1693 MODZT. We recruited 406
families with two or more sisters who had given birth to spontaneous
DZ twins (Duffy et al., 2000) and also 527 families with a single case
where at least one-third degree female relative had spontaneous DZ
twins. Samples were also obtained from parents of MODZT where
available and from additional sibs. MODZT and their families were
identified through records from our genetic epidemiology studies
using twins and their families in Australia (Lewis et al., 1996),
through organizations for mothers of twins in Australia and New
Zealand, and through appeals in the media in both countries. In the
Netherlands, ascertainment was population-based through community
records as part of a systematic recruitment to the Netherlands Twin
Register (Meulemans et al., 1996; Boomsma et al., 2002). Mothers
were explicitly asked about fertility treatments and all such cases
were excluded.
Genetic investigation was extended to a population-based control
group of 1512 Caucasian females and males (unselected for twinning
history), selected at random from the electoral roll in Australia. Study
protocols were reviewed and approved by the Human Research Ethics
Committee of the Queensland Institute of Medical Research and the
Ethics Committee of the Vrije Universiteit Hospital. Participation
was voluntary and each participant gave written informed consent.
Genomic DNA was extracted (Miller et al., 1988) from peripheral
venous blood samples. Zygosity of the mothers’ twin offspring was
determined from differences in sex, eye colour or hair colour and, in
equivocal cases, by typing nine independent microsatellite markers
(AmpFLSTRw Profiler Plus
TM
, Applied Biosystems, Foster City,
CA, USA). The probability of dizygosity given concordance of all
markers in the panel was ,1024.
Denaturing high performance liquid chromatography (DHPLC)
analysis
PCR fragments covering the entire coding sequence and intron–exon
junctions of the BMP15 gene were analysed in 279 MODZT, where
one sister was drawn from each of 279 affected sister pair families.
PCR reactions were performed in 20 ml volumes containing 15 ng
of DNA, 1 PCR buffer, 16 pmol of each primer, 1.5 mM MgCl2,
200 mM dNTPs and 1 U Amplitaq Gold (Applied Biosystems). Prior
to DHPLC, amplicons were denatured at 958C for 5 min and cooled
to 608C, dropping by 58C increments with 4 min at each temperature.
PCR products were then injected into a Varian Helix System (Varian,
Walnut Creek, CA, USA) and eluted within a linear acetonitrile gradi-
ent consisting of buffer A [0.1 M triethylammonium acetate (TEAA)
and 0.1 mM EDTA] and buffer B (0.1 M TEAA, 0.1 mM EDTA and
25% acetonitrile) with a flow rate of 0.45 ml/min. The buffer B
gradient was 45–50% (0–0.5 min), 50–68% (0.5–6 min), 68%
(6–7 min) and 68–45% (7–8 min). DHPLC was carried out, on a
fragment specific basis, at the optimal temperature as determined by
the Stanford Genome Technology Centre DHPLC melt program
(http://insertion.stanford.edu/melt.html). Analyses were performed
using the Star Workstation version 5 (Varian). The appearance of
additional peaks was interpreted as indicative of a mismatch in the
PCR fragment. For these samples, new PCR products amplifying
the entire exon of interest were generated and purified by
Microcon-PCR Centrifugal Filter devices (Millipore, Billerica, MA,
USA). BigDyew Terminator v3.1 terminator premix (Applied Biosys-
tems) was used for cycle sequencing with purified PCR products ana-
lysed with a capillary based genetic analyser.
SNP genotyping
All common, novel and POF associated SNPs were typed in the 3450
individuals from 933 twinning families and 1512 controls using the
Sequenom
TM
iPLEX
TM
protocol. Genotyping assays were designed
using MassARRAY Assay Design software (Sequenom Inc., San
Diego, CA, USA). The 2.5 ml PCR reactions were performed in stan-
dard 384-well plates using 10 ng genomic DNA, 0.5 U Taq polymer-
ase (HotStarTaq, Qiagen, Valencia, CA, USA), 500 mmol of each
dNTP and 100 nmol of each PCR primer. PCR thermal cycling in
an ABI-9700 instrument was 15 min at 948C, followed by 45 cycles
of 20 s at 948C, 30 s at 568C, 60 s at 728C. The completed PCR reac-
tions were then incubated with 0.15 U shrimp alkaline phosphatase for
30 min at 378C followed by inactivation for 5 min at 858C. After
adjusting the concentrations of extension primers to equilibrate
signal-to-noise ratios, the post-PCR primer extension reaction of the
iPLEX assay was performed in a final 5 ml extension reaction contain-
ing 0.1 ml of termination mix, 0.02 ml of DNA polymerase (Sequenom
Inc.) and 600–1200 nM extension primers. A two-step 200 short-
cycles program was used for the iPLEX extension reaction: initial
denaturation was 30 s at 948C followed by five cycles of 5 s at 528C
and 5 s at 808C. An additional 40 annealing and extension cycles
were then looped back to 5 s at 948C, 5 s at 528C and 5 s at 808C. A
final extension was carried out at 728C for 3 min and then the
sample was cooled to 208C. The iPLEX reaction products were
desalted by diluting samples with 15 ml of water and 3 ml of resin to
optimize mass spectrometric analysis. Products were spotted on a
SpectroChip (Sequenom Inc.), and processed and analysed in a
Compact Mass Spectrometer using MassARRAY Workstation
(version 3.3) software (Sequenom Inc.).
Statistical analysis
The program Sib-pair (http://www.qimr.edu.au/davidD/sib-pair.
html) was used to calculate preliminary allele and genotype frequen-
cies. Since variants were genotyped in families, the case–control com-
parisons of allele frequencies to test association allowing for the
family nature of the data were carried out using the program
MENDEL 7.0 (Lange et al., 2001). To make the comparison as
clear as possible, a case was defined as an MODZT, whereas a
control was a member (male or female) of our population-based
sample; other relatives of cases were treated as having unknown phe-
notypes. We fitted allelic association models (i.e. assuming multiplica-
tive effects on penetrance in females), and so could utilize male
BMP15 and DZ twinning
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controls (remembering that BMP15 is X-linked). For association
analysis of rare variants discovered via sequencing (where only
cases were sequenced), we carried out ascertainment correction (con-
ditioning the family likelihood on that of the sequenced proband).
Reconstruction of haplotypes consisting of four common SNPs sur-
rounding and within exon 1, and the analysis of haplotype frequencies
in MODZT and controls were performed using MENDEL 7.0.
To predict the functional significance of missense mutations, we con-
structed a multiple sequence alignment for mammalian BMP15 protein
sequences for human (NP_005439.1), macaque (XP_001083980),
chimpanzee (XP_529247), sheep (Q9MZE2), cow (NP_001026922),
pig (NP_001005155), mouse (NP_033887) and rat (NP_067702)
sequences and compared the amino acid substitutions using the
Align-GVGD program (Mathe et al., 2006) available at http://agvgd.
iarc.fr. The program uses an extension of the Grantham difference
and compares the amino acid substitutions taking into account compo-
sition, polarity and volume of amino acid substitutions within the
context of a multiple sequence alignment for the protein. Amino acid
changes are classified as to their likelihood of interfering with protein
function on a scale from class C65 (most likely) to C0 (least likely).
Results
Common SNPs
We typed 14 common SNPs located across the BMP15 locus
identified from public databases (all SNPs with rs designations)
and the literature (c.-673C.T, Moron et al., 2006; Fig. 1). Two
SNPs (rs6614369 and rs6614608) were monomorphic in our
samples and were omitted from all analyses. Genotype data
for the remaining 12 common SNPs were in Hardy–Weinberg
equilibrium, and overall minor allele frequencies ranged from
0.001 to 0.327 (Table I). The analysis of allelic association
for individual SNPs identified some evidence of association
between the DZ twinning phenotype and the intronic SNP
rs3897937 (IVS1þ905G.A) with a significantly higher fre-
quency of the A allele in MODZT than in controls (0.325
versus 0.294, P ¼ 0.010, Table II). A SNP in the promoter
region (rs3810682; c.-9C.G) also showed some evidence of
association. However, the differences in allele frequencies
between MODZT and controls were small and the effects
were not significant after correcting for multiple testing of
all SNPs.
We estimated the frequencies of haplotypes including four
common SNPs located around and within exon 1 of BMP15,
including rs3810682 and rs3897937, following recent evidence
that a haplotype comprising these SNPs is associated with the
production of increased numbers of follicles (12) during
ovarian stimulation (Moron et al., 2006). In our samples only
four haplotypes had frequencies .5% in both MODZT and
controls (Table III). One common haplotype accounted for
67% of BMP15 chromosomes among our MODZT, with the
two most frequent haplotypes accounting for .82% of
chromosomes. There were no differences in the frequencies
of haplotypes between MODZT and controls (Table III).
Novel variants in MODZT
A search for rare variants in the BMP15 gene in 279 MODZT
identified four rare missense alterations resulting in putative
changes in the amino acid sequence. Two variants
(c.520C.T, p.Pro174Ser and c.581T.C, p.Phe194Ser) were
located in the pro-region of BMP15 and two variants
(c.931G.A, p.Ala311Thr and c.1175G.C, p.Arg392Thr) in
the mature protein region. The p.Arg392Thr variant was pre-
dicted as ‘most likely’ to interfere with protein function
(Align-GVGD class C65), p.Phe194Ser and p.Ala311Thr as
slightly less likely to affect protein function (class C55, one
class below C65), whereas p.Pro174Ser is predicted to have
no effect (class C0).
These variants were then typed in all samples (Table IV).
The p.Phe194Ser variant had a higher frequency in controls
than in MODZT (0.003 versus 0.001, P ¼ 0.054). The other
three variants were seen in twinning families but not controls;
the p.Pro174Ser variant in additional members of the family in
which it was first found, the p.Ala311Thr variant in members of
the original and one additional family and the p.Arg392Thr
Figure 1: Schematic representation of the genomic structure of the BMP15 gene showing the locations of the SNPs genotyped in our DZ twinning
families, including 12 common SNPs, 4 rare variants identified in mutation screening of MODZT and 17 POF associated variants. Common SNPs
that were not polymorphic in our samples are not shown, and only the exons are drawn to scale.
Zhao et al.
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variant only in the sample in which it was first detected.
Corrected allele frequencies taking ascertainment bias into
account were not significantly different between MODZT
and controls (Table IV).
POF associated variants in MODZT
Seventeen variants in the coding regions of BMP15 and six in
GDF9 that have been previously reported in POF patients
were also typed in our 933 twinning families and 1512 controls
(Table V). Three POF associated BMP15 variants were detected
in our samples, at approximately similar minor allele frequen-
cies for both MODZT and controls (p.Arg68Trp, 0.0003
versus 0.002, P ¼ 0.303; p.Ala180Thr, 0.014 versus 0.016,
P ¼ 0.253; p. Leu263_Arg264insLeu, 0.005 versus 0.005,
P ¼ 0.406).
Three POF associated GDF9 variants were each detected in
either a single control (c.-8C.T and p.Lys67Glu) or MODZT
(p.Ser70Ser; Table V). Previously, the p.Pro103Ser variant had
been found in this cohort at a higher frequency among our
MODZT than among controls (Palmer et al., 2006; Table V).
Discussion
BMP15 is a strong candidate gene likely to contribute to the
variation in human twinning. The gene is specifically expressed
in the oocytes of developing follicles (Laitinen et al., 1998;
Table I. Common SNPs at the BMP15 locus genotyped in 933 twinning families and 1512 controls.
SNP Position* Location Amino acid change Change (transcribed strand) Minor allele frequency
rs5961228 50656568 50 genomic — C.T 0.135
rs5961233 50663804 50 genomic — C.A 0.101
rs9697841 50664677 50 genomic — T.G 0.061
rs1857030 50667633 50 genomic — T.A 0.061
c.-673C.T 50671179 50 genomic — C.T 0.240
rs3810682 50670515 50 UTR — C.G 0.232
rs41308602 50670830 Exon 1 Asn103Ser c.308A.G 0.086
rs12687730 50671338 Intron 1 — T.C 0.001
rs3897937 50671756 Intron 1 — T.C 0.294
rs17003221 50676020 Exon 2 Ser248Ser c.852C.T 0.005
rs2382663 50679039 30 genomic — G.A 0.327
rs7889321 50692668 30 genomic — A.G 0.038
*Genomic position according to NCBI Build 36.1.
Table II. Allelic association between dizygotic twinning and common SNPs at the BMP15 locus.
SNP N genotyped Minor allele frequency Allelic x2 P-value1
MODZT N ¼ 1693 Controls N ¼ 1512
rs5961228 4648 0.137 0.141 2.032 0.154
rs5961233 4633 0.102 0.103 0.002 0.952
rs9697841 4628 0.065 0.059 1.250 0.289
rs1857030 4637 0.064 0.057 1.161 0.281
c.-673C.T 4680 0.250 0.230 2.390 0.122
rs3810682 4534 0.255 0.232 3.503 0.061
rs41308602 4596 0.088 0.086 0.414 0.519
rs12687730 4613 0.0001 0.002 2.628 0.105
rs3897937 4581 0.325 0.294 6.705 0.010
rs17003221 4649 0.004 0.005 1.971 0.160
rs2382663 4563 0.319 0.328 0.614 0.433
rs7889321 4648 0.038 0.038 0.421 0.516
1Asymptotic P-values were estimated allowing for the family nature of the data using the measured genotype approach implemented in MENDEL 7.0 (Lange
et al., 2001).
Table III. Frequencies of observed haplotypes and odds ratios for MODZT (cases) and controls for four common BMP15 SNPs.
Haplotype c.-673C.T–rs3810682–rs41308602–rs3897937 Frequency MODZT Frequency controls Odds ratio
C C A A 0.668 0.692 1.000
T G A G* 0.155 0.136 0.846
T G G G* 0.077 0.092 1.153
C C A G 0.063 0.058 0.888
Rare haplotypes 0.034 0.021 0.704
Haplotypes with frequencies 0.01 in both MODZT and controls were collapsed and analysed as a single group of ‘rare haplotypes’.
*A haplotype associated with the production of high numbers of follicles during assisted reproduction by Moron et al. (2006), TGG, is composed of markers
c.-673C.T–rs3810682–rs3897937, incorporating either allele of rs41308602.
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Galloway et al., 2000; Otsuka et al., 2000) and several loss of
function mutations in sheep increase ovulation rates and litter
sizes in heterozygous carriers (Galloway et al., 2000; Hanrahan
et al., 2004). To test for association between BMP15 variants
and human twinning, we typed a total of 35 common, rare
and novel BMP15 SNPs in our DZ twinning families. The fre-
quency of the C allele of one intronic SNP (rs3897937) was
higher in MODZT than in controls, although this was not sig-
nificant after accounting for multiple testing. The analysis of
the SNPs across the BMP15 locus showed strong linkage dise-
quilibrium, with two haplotypes accounting for 82% of
chromosomes in MODZT. There were no significant associ-
ations between haplotype frequencies and the DZ twinning
phenotype.
We previously identified rare mutations in the GDF9 gene
including both insertion/deletion and missense mutations with
higher frequencies in MODZT compared with controls (Mon-
tgomery et al., 2004; Palmer et al., 2006). We carried out a
similar screen of BMP15 in 279 probands from our most twin
dense families. We found no insertion/deletion mutations, but
did identify four rare missense BMP15 mutations in our
MODZT. One of these (p.Phe194Ser) wasmore frequent in con-
trols than in MODZT, and hence can probably be considered a
rare polymorphism. The other three variants were seen only in
twinning families. However, the variant most likely to affect
protein function, p.Arg392Thr, was carried by one MODZT
but not by her sister, also an MODZT. Conversely,
p.Ala311Thr and p.Pro174Ser were detected in both MODZT
Table IV. BMP15 variants identified by DHPLC analysis of 279 MODZT.
BMP15 variant Protein variant MODZT Controls P-value
Carriers Allele freq Carriers Allele freq
c.520C.T Pro174Ser 2 0.0005 — — 0.112
c.581T.C Phe194Ser 5 0.0012 11 0.0036 0.054
c.931G.A Ala311Thr 3 0.0008 — — 0.066
c.1175G.C Arg392Thr 1 0.0002 — — 0.295
Any of the above — 11 0.0032 11 0.0036 0.168
Numbers of carriers and minor allele frequencies were determined by Sequenom MALDI-TOF SNP analysis of 933 DZ twinning families with 1693 MODZT
and 1512 controls. The P-values were calculated for the likelihood ratio test (MENDEL binomial link measured genotype model) testing for effect of the
variant on the likelihood of having twins under a multiplicative model.
Table V. Summary of mutations identified in women with premature ovarian failure (POF) in the GDF9 and BMP15 genes.
Gene and sequence change Amino Acid Change Initial study population No. POF mutations References No. of Carriers
MODZT Controls
GDF9
c.-8C.T — Indian 2/195 Dixit et al. (2005) — 1
c.199A.C Lys67Glu Indian 5/195 Dixit et al. (2005) — 1
c.205C.T Ser70Ser Indian 1/195 Dixit et al. (2005) 1 —
c.307C.T Pro103Ser Caucasian 1/61 Kovanci et al. (2007) 30* 13*
c.646G.A Val216Met Indian 2/195 Dixit et al. (2005) — —
c.1353C.T Cys461Cys Indian 3/195 Dixit et al. (2005) — —
BMP15
c.181C.T Arg61Trp Indian 2/202 Dixit et al. (2006) — —
c.182G.A Arg61Glu Indian 1/202 Dixit et al. (2006) — —
c.202C.T Arg68Trp Italian 1/166 Di Pasquale et al. (2006) 2 3
c.226C.T Arg76Cys Indian 5/202 Dixit et al. (2006) — —
c.227G.A Arg76His Indian 1/202 Dixit et al. (2006) — —
c.381A.G Leu127Leu Indian 1/202 Dixit et al. (2006) — —
c.443T.C Leu148Pro Mixed origins 1/203 Laissue et al. (2006) — —
African-American 2/14 Di Pasquale et al. (2006)
c.468G.A Val156Val Mixed origins 1/203 Laissue et al. (2006) — —
c.538G.A Ala180Thr Italian 5/166 Di Pasquale et al. (2006) 46 32
Indian 3/202 Dixit et al. (2006)
Mixed origins 2/203 Laissue et al. (2006)
c.538G.T(þ)c.539C.T Ala180Phe/SerþVal Indian 1/202 Dixit et al. (2006) — —
c.588T.A Asn196Lys Indian 1/202 Dixit et al. (2006) — —
c.617G.A Arg206His Indian 1/202 Dixit et al. (2006) — —
c.631C.T Glu211X Indian 1/202 Dixit et al. (2006) — —
c.661T.C Trp221Arg Indian 1/202 Dixit et al. (2006) — —
c.727A.G Ile243Gly Indian 1/202 Dixit et al. (2006) — —
c.788_789insTCT Leu263_Arg264insLeu Indian 9/202 Dixit et al. (2006) 16 12
c.831T.C Thr277Thr Mixed origins 1/203 Laissue et al. (2006) — —
SNPs were screened in 933 DZ twinning families (including 1693 MODZT) and 1512 controls.
*Found previously in this cohort, Palmer et al. (2006).
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and their ‘unaffected’ sisters. It is possible that these variants are
twinning associated alleles with reduced penetrance; but
although both are predicted to interfere to some degree with
protein function, whether or not they actually have an effect is
unknown. Additionally, the carrier status of all MODZT for
the p.Ala311Thr variant within one of the two families in
which it was detected cannot be determined due to the
incomplete sampling of this very large extended pedigree.
Taken together, our results suggest that the contribution of
rare variants in BMP15 to the variability in human twinning
would be small.
There are species differences in the actions of BMP15. Loss
of function mutations in humans and sheep has dramatic con-
sequences on follicle development. A mutation at codon 235
in the preproregion of human BMP15 associated with hypergo-
nadotrophic ovarian failure in two sisters with streak ovaries
(Di Pasquale et al., 2004) acts in a dominant negative
fashion, abolishing the effects of wild-type BMP15 in stimulat-
ing the growth of granulosa cells (Di Pasquale et al., 2004). In
contrast, the targeted deletion of the second exon of the Bmp15
gene in mice has limited effects on folliculogenesis (Yan et al.,
2001). Female Bmp15 knockout mice are subfertile due to
defects in the ovulation process and the ability of oocytes to
develop into normal embryos (Liao et al., 2004). The differ-
ences between these species may reflect differences in the rela-
tive importance of BMP15 and GDF9 in regulating events of
folliculogenesis (Liao et al., 2004) or may reflect the nature
of the specific mutations. Studies with a recombinant human
BMP15 p.Ile31Asp substitution (Liao et al., 2003), which
mimics the p.Val31Asp variant in the Inverdale strain of
sheep (Galloway et al., 2000), show that the variant form of
the protein interferes with proteolytic processing of both wild-
type BMP15 and also GDF9. The p.Tyr235Cys mutation in
human BMP15 associated with hypergonadotrophic ovarian
failure (Di Pasquale et al., 2004) also interferes with the pro-
cessing and secretion of bioactive proteins.
Our data suggest variation in human BMP15 plays at best a
very minor role in human DZ twinning. This contrasts with evi-
dence for sheep where at least five different BMP15 mutations
are associated with high ovulation rates and litter sizes in
different flocks, where they have attained high frequencies
due to artificial selection or genetic drift (McNatty et al.,
2004). These variants have been identified in prolific breeds
of sheep, and to date there has been no systematic screen for
variants in either BMP15 or GDF9 in the wider sheep popu-
lation to estimate the frequency of rare variants or the relative
importance of variation in these two growth factors influencing
ovulation rate. We have earlier shown that rare variants in
human GDF9, including both insertion/deletion and missense
mutations, account for 2.4% of the attributable risk for twins
(Palmer et al., 2006). Taken together, our results suggestGDF9
plays a more important role than BMP15 in the regulation of
twinning in humans (Montgomery et al., 2004; Palmer et al.,
2006). Associations between DZ twinning and variants in
other genes including FMR (Vianna-Morgante, 1999;
Marozzi et al., 2000) and SERPINA1 (Clark and Martin,
1982; Boomsma et al., 1992) have been reported, but none
have been replicated in large samples.
Four of the common BMP15 variants analysed here have
recently been associated with high response to treatment with
recombinant follicle-stimulating hormone (FSH) during
assisted reproduction (Moron et al., 2006). Minor alleles for
variants c.-673C.T plus rs3810682 (the two markers are in
almost complete linkage disequilibrium) and rs3897937, as
well as the resulting ‘TGG’ haplotype, were significantly over-
represented among 35 high FSH responders (producing 12
follicles), and particularly in the subset of 11 high responders
who developed ovarian hyperstimulation syndrome. Although
the numbers of women involved were small (11.4% and
3.6% of the women tested, respectively), this suggests a role
for BMP15 variants in the control of follicle numbers in
response to high exogenous FSH concentrations, possibly
through a functional variant linked to the TGG haplotype
(Moron et al., 2006). Raised FSH concentrations during the fol-
licular phase have been documented in MODZT (Nylander,
1974; Martin et al., 1984; Lambalk et al., 1998), and it may
be that with this haplotypic background BMP15 also influences
follicle number in response to high levels of endogenous FSH.
However, we found no evidence that the frequency of the TGG
haplotype was increased in MODZT.
Conversely, a number of recent studies identified variants in
both BMP15 and GDF9 associated with POF (Dixit et al.,
2005, 2006; Di Pasquale et al., 2006; Laissue et al., 2006).
MODZT reach menopause significantly earlier than mothers
of monozygotic twins, with the difference resulting from
some MODZT reaching menopause before age 40 (Martin
et al., 1997). This small increase in the frequency of POF in
MODZT could be explained by mutations in GDF9 and/or
BMP15 influencing both aspects of ovarian function. To test
this hypothesis, 23 GDF9 and BMP15 variants previously
associated with POF were typed in our 933 twinning families.
We have earlier shown that the GDF9 variant p.Pro103Ser, also
reported in one woman with POF (Kovanci et al., 2007), is sig-
nificantly associated with twinning (Palmer et al., 2006). We
detected three additional POF associated variants in each
gene in our MODZT and/or controls—BMP15 variants
p.Arg68Trp (Di Pasquale et al., 2006), p.Ala180Thr (Di Pas-
quale et al., 2006; Dixit et al., 2006; Laissue et al., 2006)
and p.Leu263_Arg264insLeu (Dixit et al., 2006) and GDF9
variants c.-8C.T, p.Lys67Glu and p.Ser70Ser (Dixit et al.,
2005). In previous reports, the p.Leu263_Arg264insLeu was
associated with POF in one study (Dixit et al., 2006), but not
in two others (Di Pasquale et al., 2006; Laissue et al., 2006).
This and the other variants we detected may be rare poly-
morphisms rather than mutations, and further studies are now
required to confirm whether these variants are in fact associated
with POF.
The association of the GDF9 p.Pro103Ser variant with both
twinning (Palmer et al., 2006) and POF (Kovanci et al., 2007)
might, however, support the hypothesis that earlier menopause
in mothers of twins and the twinning phenotype are related to
mutations in GDF9 and that other mutations/genes causing
POF may also be candidates for twinning. We found no glob-
ally significant association between twinning and any BMP15
variant or haplotype, but the possibility that multiple variants
might affect either POF or twinning is intriguing. Further
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studies will be required to determine if such differences reflect
the rare frequencies of these variants in each condition or
whether variants can influence POF and twinning
independently.
In conclusion, we found no evidence that either rare or
common variants in BMP15 play any significant role in the
variation in human DZ twinning. We cannot entirely rule out
weak effects or epistatic interactions with other variants, but
very large studies will be required to examine these effects.
We identified rare variants in BMP15 in MODZT, but the fre-
quencies of these were very low. There is evidence for an
association between early menopause and twinning and
although most POF variants were not found in MODZT, the
GDF9 p.Pro103Ser variant associated with twinning (Palmer
et al., 2006) has been reported in one POF patient (Kovanci
et al., 2007). Further studies should examine the relationships
between twinning and POF.
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